Literature DB >> 17626921

Oseltamivir's adverse reactions: Fifty sudden deaths may be related to central suppression.

Rokuro Hama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17626921      PMCID： PMC1914480          DOI： 10.1136/bmj.39262.448877.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Tamiflu and neuropsychiatric disturbance in adolescents.

Authors:  Simon R J Maxwell
Journal:  BMJ       Date:  2007-06-16

2.  A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir.

Authors:  Chuan-Yun Li; Quan Yu; Zhi-Qiang Ye; Ying Sun; Quanyuan He; Xiao-Mo Li; Wuxue Zhang; Jingchu Luo; Xiaocheng Gu; Xiaofeng Zheng; Liping Wei
Journal:  Cell Res       Date:  2007-04       Impact factor: 25.617
  2 in total
  10 in total

1.  Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.

Authors:  Keiko Hata; Koichi Koseki; Kazunori Yamaguchi; Setsuko Moriya; Yasuo Suzuki; Sangchai Yingsakmongkon; Go Hirai; Mikiko Sodeoka; Mark von Itzstein; Taeko Miyagi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

2.  Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication.

Authors:  Inna Karpenko; Sergey Deev; Oleg Kiselev; Valerey Charushin; Vladimir Rusinov; Eugeney Ulomsky; Ella Deeva; Dmitry Yanvarev; Alexander Ivanov; Olga Smirnova; Sergey Kochetkov; Oleg Chupakhin; Marina Kukhanova
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 3.  Antivirals for influenza: strategies for use in pediatrics.

Authors:  Steven M Smith; John G Gums
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

4.  Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo.

Authors:  Peter Fedichev; Roman Timakhov; Tim Pyrkov; Evgeny Getmantsev; Andrey Vinnik
Journal:  PLoS Curr       Date:  2011-08-07

5.  Risk factors of household transmission of pandemic (H1N1) 2009 among patients treated with antivirals: a prospective study at a primary clinic in Japan.

Authors:  Nobuo Hirotsu; Koji Wada; Hitoshi Oshitani
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 6.  Safety and efficacy of peramivir for influenza treatment.

Authors:  Atsuko Hata; Ryoko Akashi-Ueda; Kazufumi Takamatsu; Takuro Matsumura
Journal:  Drug Des Devel Ther       Date:  2014-10-24       Impact factor: 4.162

7.  Role of the ABCB1 Drug Transporter Polymorphisms in the Pharmacokinetics of Oseltamivir in Humans: a Preliminary Report.

Authors:  Yu Jung Cha; Jong Lyul Ghim
Journal:  J Korean Med Sci       Date:  2017-09       Impact factor: 2.153

8.  A Lateral Flow Immunochromato-graphic Strip Test for Rapid Detection of Oseltamivir Phosphate in Egg and Chicken Meat.

Authors:  Xingdong Yang; Jifei Yang; Yinbiao Wang; Lili Li; Zhongke Sun; Zonghao Yue; Fengshou Tian; Le He; Xiaofei Hu
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

9.  The mechanisms of delayed onset type adverse reactions to oseltamivir.

Authors:  Rokuro Hama
Journal:  Infect Dis (Lond)       Date:  2016-06-02

Review 10.  The mechanisms of sudden-onset type adverse reactions to oseltamivir.

Authors:  R Hama; C L Bennett
Journal:  Acta Neurol Scand       Date:  2016-06-30       Impact factor: 3.209
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.